the Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Cervical Cancer

Condition:   Cervical Cancer Interventions:   Drug: GX-188E;   Drug: Keytruda Sponsors:   Genexine, Inc.;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials